{
    "Orphapacket": {
        "ORPHApacketId": "206599",
        "creationDate": "2020-06-27 22:10:58",
        "version": "1.3.6 / 4.1.7 [2020-04-17] (orientdb version)",
        "copyright": "Orphanet (c) 2020",
        "ORPHAcode": "206599",
        "Label": "Isolated asymptomatic elevation of creatine phosphokinase",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_206599",
        "DisorderType": {
            "value": "Biological anomaly",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377790"
        },
        "Synonyms": [
            {
                "Synonym": "Idiopathic asymptomatic hyperCKemia"
            },
            {
                "Synonym": "Isolated asymptomatic hyperCKemia"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "Isolated asymptomatic elevation of creatine phosphokinase is a rare neurologic disease characterized by persistent elevation of the serum creatine phosphokinase (CK) without any clinical neurophysical or histopathological evidence of neuromuscular disease using the available laboratory procedures. It is usually an incidental finding diagnosed after exclusion of other possible causes of elevated CK levels."
        },
        "Genes": [
            {
                "Gene": {
                    "Symbol": "CAV3",
                    "Name": "caveolin 3",
                    "ExternalReferences": [
                        {
                            "Source": "HGNC",
                            "Reference": "1529"
                        },
                        {
                            "Source": "OMIM",
                            "Reference": "601253"
                        }
                    ]
                }
            }
        ],
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "207078",
                        "Label": "Qualitative or quantitative defects of caveolin-3"
                    }
                ]
            },
            {
                "Parent": [
                    {
                        "ORPHAcode": "207085",
                        "Label": "Qualitative or quantitative defects of dystrophin"
                    }
                ]
            }
        ],
        "Prevalences": {
            "Prevalence": [
                {
                    "Source": "ORPHANET",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Class only",
                    "PrevalenceClass": "Unknown",
                    "ValMoy": "0.0",
                    "PrevalenceGeographic": "Worldwide"
                }
            ]
        },
        "AverageAgeOfOnsets": {
            "AverageAgeOfOnset": [
                {
                    "value": "All ages"
                }
            ]
        },
        "AverageAgeOfDeaths": {
            "AverageAgeOfDeath": [
                {
                    "value": "any age"
                }
            ]
        }
    }
}